Wenzhen Yang

Years Active: 2019-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Iacovos N Michaelides, Gavin W Collie, Ulf Börjesson, Christina Vasalou, Omar Alkhatib, Louise Barlind, Tony Cheung, Ian L Dale, Kevin J Embrey, Edward J Hennessy, Puneet Khurana, Cheryl M Koh, Michelle L Lamb, Jianming Liu, Thomas A Moss, Daniel J O'Neill, Christopher Phillips, Joseph Shaw, Arjan Snijder, R Ian Storer, Christopher J Stubbs, Fujin Han, Chengzhi Li, Jingchuan Qiao, Dong-Qing Sun, Jingwen Wang, Peng Wang, Wenzhen Yang
Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor. Journal of medicinal chemistry (2023)
Matthew W D Perry, Karin Björhall, Peter Bold, Mikael Brűlls, Ulf Börjesson, Johan Carlsson, Hui-Fang Amy Chang, Yunhua Chen, Anders Eriksson, Britt-Marie Fihn, Rebecca Fransson, Linda Fredlund, Hongbin Ge, Haijuan Huang, Kostas Karabelas, Eva Lamm Bergström, Sarah Lever, Helena Lindmark, Mickael Mogemark, Antonios Nikitidis, Anna-Pia Palmgren, Nils Pemberton, Jens Petersen, Mio Rodrigo Blomqvist, Reed W Smith, Matthew J Thomas, Victoria Ullah, Christian Tyrchan, Tiiu Wennberg, Annika Westin Eriksson, Wenzhen Yang, Shuchun Zhao, Linda Öster
Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma. Journal of medicinal chemistry 64 (12) (2021)
Stefan Vollmer, Danen Cunoosamy, Huafei Lv, Huanxi Feng, Xia Li, Ziyang Nan, Wenzhen Yang, Matthew W D Perry
Design, Synthesis, and Biological Evaluation of MEK PROTACs. Journal of medicinal chemistry 63 (1) (2019)

Wenzhen Yang.css-eqlu8i{font-size:small;padding-left:4px;}